ppharmПедиатрическая фармакологияPediatric pharmacology1727-57762500-3089Издательство «ПедиатрЪ»10.15690/pf.v20i6.2664ppharm-2378Research ArticleКЛИНИЧЕСКИЙ СЛУЧАЙCASE REPORTКлинический случай аритмогенной кардиомиопатии у девочки 8 лет. Сложный путь к диагнозуArrhythmogenic Cardiomyopathy in 8-Year-Old Girl: Clinical Case. Difficult Path to Diagnosishttps://orcid.org/0000-0003-4720-9023КофейниковаО. А.KofeynikovaOlga A.

Кофейникова Ольга Александровна, младший научный сотрудник НИЦ неизвестных, редких и генетически обусловленных заболеваний 

197341, г. Санкт-Петербург, ул. Аккуратова, д. 2 

Olga A. Kofeynikova, MD

2 Akkuratova Str., St. Petersburg, 197341

kofeolyaa@gmail.comhttps://orcid.org/0000-0003-1751-1424АлексееваД. Ю.AlexeevaDarya Yu.

Алексеева Дарья Юрьевна, к.м.н. 

Санкт-Петербург

Darya Yu. Alexeeva, MD, PhD

Saint Petersburg

nik135@inbox.ruХарактероваЕ. В.CharacterovaEvgeniya V.

Характерова Евгения Викторовна 

Санкт-Петербург

Evgeniya V. Characterova, MD

Saint Petersburg

Kharakterovay97@mail.ruhttps://orcid.org/0000-0002-9349-6257КостареваА. А.KostarevaAnna A.

Костарева Анна Александровна, д.м.н. 

Санкт-Петербург

Anna A. Kostareva, MD, PhD

Saint Petersburg

akostareva@hotmail.comhttps://orcid.org/0000-0001-7336-4102ВасичкинаЕ. С.VasichkinaElena S.

Васичкина Елена Сергеевна, д.м.н. 

Санкт-Петербург

Elena S. Vasichkina, MD, PhD

Saint Petersburg

vasichkinalena@mail.ruНМИЦ им. В. А. АлмазоваРоссияAlmazov National Medical Research CentreRussian Federation202303012024206574–579Copyright © Кофейникова О.А., Алексеева Д.Ю., Характерова Е.В., Костарева А.А., Васичкина Е.С., 20232023Кофейникова О.А., Алексеева Д.Ю., Характерова Е.В., Костарева А.А., Васичкина Е.С.Kofeynikova O.A., Alexeeva D.Y., Characterova E.V., Kostareva A.A., Vasichkina E.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pedpharma.ru/jour/article/view/2378

В статье представлено описание дебюта аритмогенной кардиомиопатии с леводоминантной формы у пациентки детского возраста, которая первоначально была расценена как дилатационная кардиомиопатия. Клинический случай демонстрирует сложности дифференциальной диагностики данного заболевания и необходимость комплексного подхода к обследованию пациента, включая проведение магнитно-резонансной томографии сердца и генетического анализа.

This article describes the onset of arrhythmogenic cardiomyopathy, left-dominant form, in a pediatric patient that was initially regarded as dilated cardiomyopathy. This clinical case shows issues of the disease differential diagnosis and the need of complex approach to the patient’s examination including heart magnetic resonance imaging and molecular and genetic testing.

аритмогенная кардиомиопатиядилатационная кардиомиопатиявнезапная сердечная смертьдетиarrhythmogenic cardiomyopathydilated cardiomyopathysudden cardiac deathchildrenИсследование выполнено при финансовой поддержке Министерства науки и высшего образования Российской Федерации (Соглашение № 075-15-2022-301 от 20.04.2022).The study was conducted with financial support of the Ministry of Science and Higher Education of the Russian Federation (Agreement №075-15-2022-301 from 20.04.2022).ReferencesCorrado D, Link MS, Calkins H. Arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2017;376(1):61–72. doi: https://doi.org/10.1056/NEJMra1509267Corrado D, Link MS, Calkins H. Arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2017;376(1):61–72. doi: https://doi.org/10.1056/NEJMra1509267Basso C, Corrado D, Marcus FI, et al. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373:1289–1300. doi: https://doi.org/10.1016/S0140-6736(09)60256-7Basso C, Corrado D, Marcus FI, et al. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373:1289–1300. doi: https://doi.org/10.1016/S0140-6736(09)60256-7Towbin JA, McKenna WJ, Abrams DJ, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm. 2019;16(11):e301–e372. doi: https://doi.org/10.1016/j.hrthm.2019.05.007Towbin JA, McKenna WJ, Abrams DJ, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm. 2019;16(11):e301–e372. doi: https://doi.org/10.1016/j.hrthm.2019.05.007Corrado D, Basso C. Arrhythmogenic left ventricular cardiomyopathy. Heart. 2022;108(9):733–743. doi: https://doi.org/10.1136/heartjnl-2020-316944Corrado D, Basso C. Arrhythmogenic left ventricular cardiomyopathy. Heart. 2022;108(9):733–743. doi: https://doi.org/10.1136/heartjnl-2020-316944Mazić S, Lazović B, Delić M. Arrhythmogenic right ventricular cardiomyopathy as a cause of sudden death in young people--literature review. Med Pregl. 2012;65(9-10):396–404. doi: https://doi.org/10.2298/mpns1210396mMazić S, Lazović B, Delić M. Arrhythmogenic right ventricular cardiomyopathy as a cause of sudden death in young people--literature review. Med Pregl. 2012;65(9-10):396–404. doi: https://doi.org/10.2298/mpns1210396mCadrin-Tourigny J, Bosman LP, Wang W, et al. Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Collaboration. Circ Arrhythm Electrophysiol. 2021;14(1):e008509. doi: https://doi.org/10.1161/CIRCEP.120.008509Cadrin-Tourigny J, Bosman LP, Wang W, et al. Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Collaboration. Circ Arrhythm Electrophysiol. 2021;14(1):e008509. doi: https://doi.org/10.1161/CIRCEP.120.008509Miles C, Finocchiaro G, Papadakis M, et al. Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy. Circulation. 2019;139(15):1786–1797. doi: https://doi.org/10.1161/CIRCULATIONAHA.118.037230Miles C, Finocchiaro G, Papadakis M, et al. Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy. Circulation. 2019;139(15):1786–1797. doi: https://doi.org/10.1161/CIRCULATIONAHA.118.037230Sen-Chowdhry S, Syrris P, McKenna WJ. Role of Genetic Analysis in the Management of Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. J Am Coll Cardiol. 2007;50(19):1813–1821. doi: https://doi.org/10.1016/j.jacc.2007.08.008Sen-Chowdhry S, Syrris P, McKenna WJ. Role of Genetic Analysis in the Management of Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. J Am Coll Cardiol. 2007;50(19):1813–1821. doi: https://doi.org/10.1016/j.jacc.2007.08.008Corrado D, Perazzolo Marra M, Zorzi A, et al. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int J Cardiol. 2020;319:106–114. doi: https://doi.org/10.1016/j.ijcard.2020.06.005Corrado D, Perazzolo Marra M, Zorzi A, et al. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int J Cardiol. 2020;319:106–114. doi: https://doi.org/10.1016/j.ijcard.2020.06.005Molitor N, Duru F. Arrhythmogenic Right Ventricular Cardiomyopathy and Differential Diagnosis with Diseases Mimicking Its Phenotypes. J Clin Med. 2022;11(5):1230. doi: https://doi.org/10.3390/jcm11051230Molitor N, Duru F. Arrhythmogenic Right Ventricular Cardiomyopathy and Differential Diagnosis with Diseases Mimicking Its Phenotypes. J Clin Med. 2022;11(5):1230. doi: https://doi.org/10.3390/jcm11051230Altmayer S, Nazarian S, Han Y. Left Ventricular Dysfunction in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Can We Separate ARVC from Other Arrhythmogenic Cardiomyopathies? J Am Heart Assoc. 2020;9(23):e018866. doi: https://doi.org/10.1161/JAHA.120.018866Altmayer S, Nazarian S, Han Y. Left Ventricular Dysfunction in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Can We Separate ARVC from Other Arrhythmogenic Cardiomyopathies? J Am Heart Assoc. 2020;9(23):e018866. doi: https://doi.org/10.1161/JAHA.120.018866Cohen MI, Atkins MB. Arrhythmogenic right ventricular cardiomyopathy in the pediatric population. Curr Opin Cardiol. 2022;37(1):99–108. doi: https://doi.org/10.1097/HCO.0000000000000937Cohen MI, Atkins MB. Arrhythmogenic right ventricular cardiomyopathy in the pediatric population. Curr Opin Cardiol. 2022;37(1):99–108. doi: https://doi.org/10.1097/HCO.0000000000000937Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Eur Heart J. 2010;31(7):806–814. doi: https://doi.org/10.1093/eurheartj/ehq025Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Eur Heart J. 2010;31(7):806–814. doi: https://doi.org/10.1093/eurheartj/ehq025Corrado D, Zorzi A, Cipriani A, et al. Scarring/arrhythmogenic cardiomyopathy. Eur Heart J Suppl. 2023;25(Suppl C):C144–C154. doi: https://doi.org/10.1093/eurheartjsupp/suad017Corrado D, Zorzi A, Cipriani A, et al. Scarring/arrhythmogenic cardiomyopathy. Eur Heart J Suppl. 2023;25(Suppl C):C144–C154. doi: https://doi.org/10.1093/eurheartjsupp/suad017Макаров Л.М. ЭКГ в педиатрии. — 3-е изд. — М.: Медпрактика-М; 2013. — 696 с.Makarov LM. EKG v pediatrii. 3rd ed. Moscow: Medpraktika-M; 2013. 696 p. (In Russ).]Макаров Л.М. Нормативные параметры ЭКГ у детей: методические рекомендации. — М.: Медпрактика-М; 2018. — 17 с.Makarov LM. Normativnye parametry EKG u detei: Guidelines. Moscow: Medpraktika-M; 2018. 17 p. (In Russ).]Zhang L, Liu L, Kowey PR, et al. The electrocardiographic manifestations of arrhythmogenic right ventricular dysplasia. Curr Cardiol Rev. 2014;10(3):237–245. doi: https://doi.org/10.2174/1573403x10666140514102928Zhang L, Liu L, Kowey PR, et al. The electrocardiographic manifestations of arrhythmogenic right ventricular dysplasia. Curr Cardiol Rev. 2014;10(3):237–245. doi: https://doi.org/10.2174/1573403x10666140514102928Алексеева Д.Ю., Кофейникова О.А., Марапов Д.И., Васичкина Е.С. Электрокардиографические параметры и особенности желудочковых нарушений ритма при различных фенотипических формах аритмогенной кардиомиопатии в педиатрической популяции: систематический обзор и метаанализ // Российский кардиологический журнал. — 2022. — Т. 27. — № 3S. — С. 91–100. — doi: https://doi.org/10.15829/1560-4071-2022-5147Alekseeva DYu, Kofeynikova OA, Marapov DI, Vasichkina ES. Electrocardiographic parameters and features of ventricular arrhythmias in various arrhythmogenic cardiomyopathy forms in the pediatric population: a systematic review and meta-analysis. Russian Journal of Cardiology. 2022;27(3S):91–100. (In Russ). doi: https://doi.org/10.15829/1560-4071-2022-5147]Bariani R, Rigato I, Cipriani A, et al. Myocarditis-like Episodes in Patients with Arrhythmogenic Cardiomyopathy: A Systematic Review on the So-Called Hot-Phase of the Disease. Biomolecules. 2022;12(9):1324. doi: https://doi.org/10.3390/biom12091324Bariani R, Rigato I, Cipriani A, et al. Myocarditis-like Episodes in Patients with Arrhythmogenic Cardiomyopathy: A Systematic Review on the So-Called Hot-Phase of the Disease. Biomolecules. 2022;12(9):1324. doi: https://doi.org/10.3390/biom12091324Scheel PJ 3rd, Giuliano K, Tichnell C, et al. Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience. ESC Heart Fail. 2022;9(2):1008–1017. doi: https://doi.org/10.1002/ehf2.13757Scheel PJ 3rd, Giuliano K, Tichnell C, et al. Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience. ESC Heart Fail. 2022;9(2):1008–1017. doi: https://doi.org/10.1002/ehf2.13757Christensen AH, Platonov PG, Jensen HK, et al. Genotype-phenotype correlation in arrhythmogenic right ventricular cardiomyopathy-risk of arrhythmias and heart failure. J Med Genet. 2022;59(9):858–864. doi: https://doi.org/10.1136/jmedgenet-2021-107911Christensen AH, Platonov PG, Jensen HK, et al. Genotype-phenotype correlation in arrhythmogenic right ventricular cardiomyopathy-risk of arrhythmias and heart failure. J Med Genet. 2022;59(9):858–864. doi: https://doi.org/10.1136/jmedgenet-2021-107911Protonotarios A, Bariani R, Cappelletto C, et al. Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator. Eur Heart J. 2022;43(32):3053–3067. doi: https://doi.org/10.1093/eurheartj/ehac235Protonotarios A, Bariani R, Cappelletto C, et al. Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator. Eur Heart J. 2022;43(32):3053–3067. doi: https://doi.org/10.1093/eurheartj/ehac235

The authors declare that there are no conflicts of interest present.